ABVC - ABVC BIOPHARMA, INC.

1
-0.060   -6.000%

Share volume: 75,271
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.18%

PREVIOUS CLOSE
CHG
CHG%
$1.06
-0.06
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-17-2024 08-14-2024 11-14-2024 04-30-2025 08-13-2025 10-31-2025 03-03-2026
Total revenue 1.205 K 117.620 K 401.276 K 12.000 K 12.000 K 795.950 K -685.754 K
Cost of revenue 277.000 190.000 296.000 0.000 0.000 0.000 0.000
Gross profit 928.000 116.952 K 388.980 K 0.000 0.000 795.950 K -795.950 K
    12,502.59% 232.60% -100.00% nan% inf% -200.00%  
Operating expenses 900.323 K 680.852 K 339.033 K 644.232 K 723.370 K 828.143 K 812.698 K
Selling general and admin 831.257 K 640.451 K 301.208 K 615.371 K 690.094 K 798.253 K 783.640 K
Research and development 69.066 K 40.401 K 37.825 K 28.861 K 33.276 K 29.890 K 29.058 K
Total expenses 3.445 M 1.094 M 339.033 K 693.005 K 2.295 M 1.964 M 2.199 M
    -68.26% -69.00% 104.41% 231.16% -14.41% 11.94%  
Operating income -3.444 M -976.641 K 49.947 K -693.005 K -2.295 M -1.168 M -2.995 M
Ebit -3.300 M -1.151 M 97.240 K -701.417 K -2.166 M -1.279 M -3.096 M
Pretax income -3.981 M -1.384 M -133.917 K -944.190 K -2.309 M -1.287 M -3.812 M
    -65.25% -90.32% 605.06% 144.57% -44.27% 196.23%  
Income tax 0.000 -110.894 K 355.000 0.000 23.627 K 527.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -3.981 M -1.273 M -134.272 K -944.190 K -2.333 M -1.288 M -3.812 M
    68.03% 89.45% -603.19% -147.07% 44.81% -196.10%